Nautilus Biotechnology Price Target Increased by 60% to $4.08

Nautilus Biotechnology's average one-year price target has been increased to $4.08/share, a 60% rise from the prior estimate of $2.55/share. The target is an average of analysts' estimates, ranging from $4.04 to $4.20/share. The price target represents a 7.94% increase from the latest closing price of $3.78/share. The put/call ratio is 0.02, indicating a bullish outlook.